SB-268091

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSB-268091
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsComplicated Skin and Soft Tissue InfectionsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A